BCR::ABL1阻害剤に対する細胞内抵抗性

Nataly Cruz-Rodriguez¹, Yulieth Torres-Llanos¹, Michael W Deininger¹

¹Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Ann Arbor, MI.

Haematologica

|February 12, 2026

まとめ

タイロシンキナーゼ阻害剤 (TKIs) による慢性骨髄性白血病 (CML) 治療は生存率を向上させていますが,耐性が持続しています. BCR::ABL1 独立した抵抗メカニズムを理解することは,新しい治療法の開発に不可欠です.

科学分野:

血液学ヘマトロジ
腫瘍学腫瘍学
分子生物学は分子生物学である.

背景:

ティロシンキナーゼ阻害剤 (TKIs) は慢性骨髄性白血病 (CML) の治療に革命を起こし,患者の生存率を大幅に改善しました.
TKIの成功にもかかわらず,薬物耐性や持続的な最小残留疾患などの課題が残っており,さらなる研究が必要である.

研究の目的:

BCR::ABL1キナーゼ活性化とBCR::ABL1独立経路を含むCMLにおける細胞内在の抵抗メカニズムをレビューする.
CMLがTKI効果を回避する方法を探求し,キナーゼ活動を超えたBCR::ABL1機能の過小評価された役割を提案する.

主な方法:

CMLにおける細胞内在の抵抗メカニズムに関する文献レビュー.
BCR::ABL1駆動による血液形成幹細胞と祖先細胞の再プログラミングの分析.

主要な成果:

TKI治療を受けている患者は,ほぼ正常な生存率を示していますが,レジスタンスと残留白血病は持続しています.
BCR::ABL1に独立する抵抗メカニズムは,TKI不全と疾患進行に寄与する.
キナーゼ活性以外のBCR::ABL1機能は,CMLの病原性において重要な役割を果たす可能性があります.

結論:

多様な抵抗メカニズムを理解することは,CMLにおけるTKIの限界を克服するための鍵です.
BCR::ABL1機能を対象にキナーゼ活性を超えて,潜在的に退廃剤を使用することで,有望な治療戦略を提供します.

さらに関連する動画

12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.3K

08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.6K

関連する概念動画

02:18

Intrinsically Disordered Proteins

19.6K

Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...

19.6K

02:18

Intrinsically Disordered Proteins

2.9K

01:52

Eukaryotic Transcription Inhibitors

11.1K

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

11.1K

01:20

Extrinsic and Intrinsic Pathways of Hemostasis

13.2K

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

13.2K

01:31

The Intrinsic Apoptotic Pathway

8.7K

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

8.7K

01:22

Resistivity

4.6K

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as: